These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 29778517)

  • 1. Production and efficacy of a low-cost recombinant pneumococcal protein polysaccharide conjugate vaccine.
    Herbert JA; Kay EJ; Faustini SE; Richter A; Abouelhadid S; Cuccui J; Wren B; Mitchell TJ
    Vaccine; 2018 Jun; 36(26):3809-3819. PubMed ID: 29778517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a conjugate vaccine against invasive pneumococcal disease based on capsular polysaccharides coupled with PspA/family 1 protein of Streptococcus pneumoniae.
    Lin H; Peng Y; Lin Z; Zhang S; Guo Y
    Microb Pathog; 2015; 83-84():35-40. PubMed ID: 25959527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experience with pneumococcal polysaccharide conjugate vaccine (conjugated to CRM197 carrier protein) in children and adults.
    Durando P; Faust SN; Fletcher M; Krizova P; Torres A; Welte T
    Clin Microbiol Infect; 2013 Oct; 19 Suppl 1():1-9. PubMed ID: 24083785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine compared to a 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naive adults.
    Jackson LA; Gurtman A; van Cleeff M; Jansen KU; Jayawardene D; Devlin C; Scott DA; Emini EA; Gruber WC; Schmoele-Thoma B
    Vaccine; 2013 Aug; 31(35):3577-84. PubMed ID: 23688526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of pneumococcal polysaccharide vaccine on nonbacteremic pneumococcal pneumonia.
    Weiser JN; Austrian R
    Clin Infect Dis; 2007 Apr; 44(8):1139-40; author reply 1140-1. PubMed ID: 17366469
    [No Abstract]   [Full Text] [Related]  

  • 6. An evaluation of emerging vaccines for childhood pneumococcal pneumonia.
    Webster J; Theodoratou E; Nair H; Seong AC; Zgaga L; Huda T; Johnson HL; Madhi S; Rubens C; Zhang JS; El Arifeen S; Krause R; Jacobs TA; Brooks AW; Campbell H; Rudan I
    BMC Public Health; 2011 Apr; 11 Suppl 3(Suppl 3):S26. PubMed ID: 21501444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pneumococcal conjugate vaccine use in adults - Addressing an unmet medical need for non-bacteremic pneumococcal pneumonia.
    Sings HL
    Vaccine; 2017 Sep; 35(40):5406-5417. PubMed ID: 28602602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of initial vaccination with 13-valent pneumococcal conjugate vaccine or 23-valent pneumococcal polysaccharide vaccine on anti-pneumococcal responses following subsequent pneumococcal vaccination in adults 50 years and older.
    Jackson LA; Gurtman A; van Cleeff M; Frenck RW; Treanor J; Jansen KU; Scott DA; Emini EA; Gruber WC; Schmoele-Thoma B
    Vaccine; 2013 Aug; 31(35):3594-602. PubMed ID: 23688525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults 70 years of age and older previously vaccinated with 23-valent pneumococcal polysaccharide vaccine.
    Jackson LA; Gurtman A; Rice K; Pauksens K; Greenberg RN; Jones TR; Scott DA; Emini EA; Gruber WC; Schmoele-Thoma B
    Vaccine; 2013 Aug; 31(35):3585-93. PubMed ID: 23688527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pneumococcal conjugate vaccine for young children.
    Selman S; Hayes D; Perin LA; Hayes WS
    Manag Care; 2000 Sep; 9(9):49-52, 54, 56-7 passim. PubMed ID: 11116663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of pneumococcal polysaccharide conjugate vaccine with long spacer arm.
    Wu D; Ji S; Hu T
    Vaccine; 2013 Nov; 31(48):5623-6. PubMed ID: 24120485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation and Characterization of Human Monoclonal Antibodies to Pneumococcal Capsular Polysaccharide 3.
    Babb R; Doyle CR; Pirofski LA
    Microbiol Spectr; 2021 Dec; 9(3):e0144621. PubMed ID: 34756090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity differences of a 15-valent pneumococcal polysaccharide conjugate vaccine (PCV15) based on vaccine dose, route of immunization and mouse strain.
    Caro-Aguilar I; Indrawati L; Kaufhold RM; Gaunt C; Zhang Y; Nawrocki DK; Giovarelli C; Winters MA; Smith WJ; Heinrichs J; Skinner JM
    Vaccine; 2017 Feb; 35(6):865-872. PubMed ID: 28087148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of 5-valent conjugate pneumococcal protein A - Capsular polysaccharide pneumococcal vaccine against invasive pneumococcal disease.
    Meng C; Lin H; Huang J; Wang H; Cai Q; Fang L; Guo Y
    Microb Pathog; 2009 Sep; 47(3):151-6. PubMed ID: 19467319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of previous vaccination with pneumococcal conjugate vaccine on pneumococcal polysaccharide vaccine antibody responses.
    Schaballie H; Wuyts G; Dillaerts D; Frans G; Moens L; Proesmans M; Vermeulen F; De Boeck K; Meyts I; Bossuyt X
    Clin Exp Immunol; 2016 Aug; 185(2):180-9. PubMed ID: 26939935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospects for pneumococcal vaccination in African children.
    Obaro SK
    Acta Trop; 2000 Mar; 75(2):141-53. PubMed ID: 10708654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Pneumococcal Protein-Polysaccharide Conjugate Vaccine Based on Biotin-Streptavidin.
    Guo M; Guo X; Zhang C; Zhu S; Zhang Y; Gu T; Kong W; Wu Y
    Infect Immun; 2022 Jan; 90(1):e0035221. PubMed ID: 34694917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in Homing Potentials of Streptococcus pneumoniae-Specific Plasmablasts in Pneumococcal Pneumonia and After Pneumococcal Polysaccharide and Pneumococcal Conjugate Vaccinations.
    Palkola NV; Pakkanen SH; Kantele JM; Pakarinen L; Puohiniemi R; Kantele A
    J Infect Dis; 2015 Oct; 212(8):1279-87. PubMed ID: 25838267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative evaluation of a newly developed 13-valent pneumococcal conjugate vaccine in a mouse model.
    Park C; Kwon EY; Choi SM; Cho SY; Byun JH; Park JY; Lee DG; Kang JH; Shin J; Kim H
    Hum Vaccin Immunother; 2017 May; 13(5):1169-1176. PubMed ID: 27960627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A platform for glycoengineering a polyvalent pneumococcal bioconjugate vaccine using E. coli as a host.
    Harding CM; Nasr MA; Scott NE; Goyette-Desjardins G; Nothaft H; Mayer AE; Chavez SM; Huynh JP; Kinsella RL; Szymanski CM; Stallings CL; Segura M; Feldman MF
    Nat Commun; 2019 Feb; 10(1):891. PubMed ID: 30792408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.